Line 12: |
Line 12: |
| | | |
| *Pathogens belong to the ''Mycoplasma'' and ''Ureaplasma'' genera | | *Pathogens belong to the ''Mycoplasma'' and ''Ureaplasma'' genera |
− | *Cause many diseases including contagious bovine pleuropneumonia | + | *Cause many diseases especially respiratory diseases of farm animals including contagious bovine pleuropneumonia |
| + | *Can be involved in mastitis and conjunctivitis in cattle |
| + | *Implicated in respiratory and urinary tract diseases in dogs and cats |
| *Non-pathogenic mycoplasmas present in the rumen | | *Non-pathogenic mycoplasmas present in the rumen |
| *Live on mucous membranes of oronasal cavity, conjunctiva and intestines | | *Live on mucous membranes of oronasal cavity, conjunctiva and intestines |
| + | *Stress factors and concurrent disease may predispose to tissue invasion |
| *Usually host-specific | | *Usually host-specific |
| *Limited survival in the environment | | *Limited survival in the environment |
| | | |
| | | |
− | ====Characteristics===
| + | ===Characteristics=== |
| | | |
| *Smallest free-living prokaryotic organism | | *Smallest free-living prokaryotic organism |
Line 28: |
Line 31: |
| *Colonies have a fried egg appearance | | *Colonies have a fried egg appearance |
| *Most are facultative anaerobes | | *Most are facultative anaerobes |
− | *''Ureaplasmas'' produce urease, whereas ''Mycoplasmas'' do not metabolise urea
| |
− | *Serolgy is required for specific identification
| |
− | *Growth inhibition tests using specific antisera can be used as well as fluorescent antibody tests
| |
| | | |
| | | |
Line 39: |
Line 39: |
| *Mycoplasmas induce proliferation of macrophages and monocytes, and release of cytokines such as TNF and interleukins | | *Mycoplasmas induce proliferation of macrophages and monocytes, and release of cytokines such as TNF and interleukins |
| *Cause damage to cilia in the respiratory tract leading to pneumonia | | *Cause damage to cilia in the respiratory tract leading to pneumonia |
| + | *Molecular mimicry allows some mycoplasmas to avoid the host immune response and may initiate immune-mediated disease |
| + | |
| + | |
| + | ===Diagnosis=== |
| + | |
| + | *Samples can be tested for the presence of mycoplasmas by fluorescent antibody techniques, peroxidase techniques and PCR |
| + | *Biochemical profiles such as urease production can be used for identification |
| + | *''Ureaplasmas'' produce urease, whereas ''Mycoplasmas'' do not metabolise urea |
| + | *Serolgy is required for specific identification including complement fixation tests, ELISA, agglutination tests and haemagglutination-inhibition tests |
| + | *Growth inhibition tests using specific antisera can be used as well as fluorescent antibody tests |
| + | |
| | | |
− | === | + | ===Clinical infections=== |
| | | |
| + | * |
| | | |
| | | |